[DISCLOSURE] IntRon Biotechnology (048530) announced on Aug. 3 that is has obtained a US patent for technology related to prevention and treatment of E. coli infection based on bacteriophage.
Intron Biotech obtains US patent for E. coli infection treatment
Published : Aug. 3, 2016 - 11:14:24
